Skip to main content
. 2024 Apr 25;44(5):293–301. doi: 10.1007/s40261-024-01355-1

Table 2.

Differentials and ratios of QALY losses between Group 1 (Placebo) and Group 2 (RZV) by trial

Study/RCT Group 1 (Placebo) Group 2 (RZV) Differential QALY loss (Group 1 – Group 2) QALY loss ratio (Group 1/Group 2)
ZOE-50 0.010271 0.002543 0.007728 4.038930
ZOE-70 0.007286 0.003771 0.003514 1.932113
ZOE-HSCT 0.012913 0.002149 0.010764 6.008841

QALY quality-adjusted life-year, RCT randomized controlled trial, RZV recombinant zoster vaccine